• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液灌流作为血液透析辅助手段的应用。

The use of hemoperfusion as an adjunct to hemodialysis.

作者信息

Trafford A, Ireland R, Evans R

出版信息

Artif Organs. 1979 Aug;3(3):249-52. doi: 10.1111/j.1525-1594.1979.tb01058.x.

DOI:10.1111/j.1525-1594.1979.tb01058.x
PMID:533415
Abstract

Studies are reported on the use of short dialysis, sequential ultrafiltration/short dialysis and hemoperfusion in chronic renal failure. Short dialysis (less than 12 hours/week) is a satisfactory regime with good patient acceptance, adequate small and middle molecule clearance and control of fluid and blood pressure. Sequential ultrafiltration in the first hour improves fluid removal and reduces the side effects of dialysis. The addition of hemoperfusion increases clearance of small and middle molecules and has little effect on the osmolality of the serum. Thus, it does not increase the side effects of dialysis. Preliminary results suggest that hemoperfusion may be useful in the treatment of chronic renal failure in combination with ultrafiltration and dialysis.

摘要

报告了关于在慢性肾衰竭中使用短程透析、序贯超滤/短程透析和血液灌流的研究。短程透析(每周少于12小时)是一种令人满意的方案,患者接受度良好,对小分子和中分子有足够的清除率,并能控制液体和血压。在第一小时进行序贯超滤可改善液体清除并减少透析的副作用。添加血液灌流可增加小分子和中分子的清除率,且对血清渗透压影响很小。因此,它不会增加透析的副作用。初步结果表明,血液灌流与超滤和透析联合应用可能对慢性肾衰竭的治疗有用。

相似文献

1
The use of hemoperfusion as an adjunct to hemodialysis.血液灌流作为血液透析辅助手段的应用。
Artif Organs. 1979 Aug;3(3):249-52. doi: 10.1111/j.1525-1594.1979.tb01058.x.
2
Removal of endogenous middle molecules by hemoperfusion.通过血液灌流清除内源性中分子物质。
Artif Organs. 1979 May;3(2):132-6. doi: 10.1111/j.1525-1594.1979.tb01025.x.
3
Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia.我们在慢性尿毒症患者中联合进行血液透析-血液灌流治疗的经验。
Biomater Artif Cells Artif Organs. 1987;15(1):175-81. doi: 10.3109/10731198709118517.
4
[A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].[慢性尿毒症患者血液灌流与血液透析过程中血浆中、分子量分子及肌醇清除效率的比较]
Pol Tyg Lek. 1978 Feb 13;33(7):257-9.
5
Serum chromatographic pattern in different dialysis strategies.不同透析策略下的血清色谱图
Int J Artif Organs. 1978 Sep;1(5):218-23.
6
Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.在接受血液透析的患者中,通过用十六烷基固定化纤维素珠进行直接血液灌流吸附蛋白结合型尿毒症毒素。
Artif Organs. 2018 Jan;42(1):88-93. doi: 10.1111/aor.12961. Epub 2017 Jul 13.
7
The optimal timing of hemoperfusion component in combined hemodialysis-hemoperfusion treatment for uremic toxins removal.血液透析-血液灌流联合治疗中用于清除尿毒症毒素的血液灌流组件的最佳时机。
Ren Fail. 2015 Feb;37(1):103-7. doi: 10.3109/0886022X.2014.976131. Epub 2014 Nov 25.
8
Comparison of haemodialysis (HD) and post dilution haemofiltration (HF) on an unselected dialysis population.
Proc Eur Dial Transplant Assoc. 1978;15:228-35.
9
Use of combined hemodialysis/hemoperfusion in chronic uremia.血液透析联合血液灌流在慢性尿毒症中的应用。
Contrib Nephrol. 1982;29:123-32. doi: 10.1159/000406184.
10
Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency.去铁胺输注后尿毒症患者采用血液透析、血液滤过和活性炭血液灌流进行铝清除。效率比较。
Nephron. 1989;51(3):325-9. doi: 10.1159/000185317.